Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigitte Murat

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Molecular Endocrinology (Baltimore, Md.)|November 4, 2006
Mapping the binding site of arginine vasopressin to V1a and V1b vasopressin receptorsJordi Rodrigo, Ana Pena, Brigitte Murat, et al.
Critical Care Medicine|February 25, 2009
Terlipressin, a provasopressin drug exhibits direct vasoconstrictor properties: consequences on heart perfusion and performanceFrédérique Ryckwaert, Anne Virsolvy, Aurélie Fort, et al.
Journal of Medicinal Chemistry|March 25, 2011
Design, synthesis, and pharmacological characterization of fluorescent peptides for imaging human V1b vasopressin or oxytocin receptorsMaithé Corbani, Miguel Trueba, Stoytcho Stoev, et al.
Molecular Endocrinology (Baltimore, Md.)|February 4, 2012
V1b and CRHR1 receptor heterodimerization mediates synergistic biological actions of vasopressin and CRHBrigitte Murat, Dominic Devost, Miriam Andrés, et al.
Journal of Medicinal Chemistry|February 16, 2007
Design and synthesis of the first selective agonists for the rat vasopressin V(1b) receptor: based on modifications of deamino-[Cys1]arginine vasopressin at positions 4 and 8Ana Pena, Brigitte Murat, Miguel Trueba, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|September 1, 2005
Position 4 analogues of [deamino-Cys(1)] arginine vasopressin exhibit striking species differences for human and rat V(2)/V(1b) receptor selectivityGilles Guillon, Ana Pena, Brigitte Murat, et al.
Nature Communications|November 12, 2022
Computationally designed GPCR quaternary structures bias signaling pathway activationJustine S Paradis, Xiang Feng, Brigitte Murat, et al.
Endocrinology|May 15, 2007
Pharmacological and physiological characterization of d[Leu4, Lys8]vasopressin, the first V1b-selective agonist for rat vasopressin/oxytocin receptorsAna Pena, Brigitte Murat, Miguel Trueba, et al.
ACS Medicinal Chemistry Letters|January 19, 2019
Tetrahydroisoquinoline CXCR4 Antagonists Adopt a Hybrid Binding Mode within the Peptide Subpocket of the CXCR4 ReceptorBrooke M Katzman, Bryan D Cox, Anthony R Prosser, et al.
Nature Communications|April 18, 2020
Author Correction: Exploring use of unsupervised clustering to associate signaling profiles of GPCR ligands to clinical responseBesma Benredjem, Jonathan Gallion, Dennis Pelletier, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Molecular Endocrinology (Baltimore, Md.)|November 4, 2006
Mapping the binding site of arginine vasopressin to V1a and V1b vasopressin receptorsJordi Rodrigo, Ana Pena, Brigitte Murat, et al.
Critical Care Medicine|February 25, 2009
Terlipressin, a provasopressin drug exhibits direct vasoconstrictor properties: consequences on heart perfusion and performanceFrédérique Ryckwaert, Anne Virsolvy, Aurélie Fort, et al.
Journal of Medicinal Chemistry|March 25, 2011
Design, synthesis, and pharmacological characterization of fluorescent peptides for imaging human V1b vasopressin or oxytocin receptorsMaithé Corbani, Miguel Trueba, Stoytcho Stoev, et al.
Molecular Endocrinology (Baltimore, Md.)|February 4, 2012
V1b and CRHR1 receptor heterodimerization mediates synergistic biological actions of vasopressin and CRHBrigitte Murat, Dominic Devost, Miriam Andrés, et al.
Journal of Medicinal Chemistry|February 16, 2007
Design and synthesis of the first selective agonists for the rat vasopressin V(1b) receptor: based on modifications of deamino-[Cys1]arginine vasopressin at positions 4 and 8Ana Pena, Brigitte Murat, Miguel Trueba, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|September 1, 2005
Position 4 analogues of [deamino-Cys(1)] arginine vasopressin exhibit striking species differences for human and rat V(2)/V(1b) receptor selectivityGilles Guillon, Ana Pena, Brigitte Murat, et al.
Nature Communications|November 12, 2022
Computationally designed GPCR quaternary structures bias signaling pathway activationJustine S Paradis, Xiang Feng, Brigitte Murat, et al.
Endocrinology|May 15, 2007
Pharmacological and physiological characterization of d[Leu4, Lys8]vasopressin, the first V1b-selective agonist for rat vasopressin/oxytocin receptorsAna Pena, Brigitte Murat, Miguel Trueba, et al.
ACS Medicinal Chemistry Letters|January 19, 2019
Tetrahydroisoquinoline CXCR4 Antagonists Adopt a Hybrid Binding Mode within the Peptide Subpocket of the CXCR4 ReceptorBrooke M Katzman, Bryan D Cox, Anthony R Prosser, et al.
Nature Communications|April 18, 2020
Author Correction: Exploring use of unsupervised clustering to associate signaling profiles of GPCR ligands to clinical responseBesma Benredjem, Jonathan Gallion, Dennis Pelletier, et al.
Pageof 2